Interleukin-2, Ipilimumab, and Anti-PD-1: clinical management and the evolving role of immunotherapy for the treatment of patients with metastatic melanoma-Reference-Cited by-同舟云学术

Interleukin-2, Ipilimumab, and Anti-PD-1: clinical management and the evolving role of immunotherapy for the treatment of patients with metastatic melanoma

Published:2021-11-19 Issue:10-12 Volume:22 Page:513-526
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Hughes Tasha¹,Klairmont Matthew¹,Sharfman William H.²^ORCID,Kaufman Howard L.³

Affiliation:

1. Rush University Cancer Center, Chicago, IL, USA

2. Johns Hopkins Medicine, Baltimore, MD, USA

3. Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA

Funder

no funding

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384047.2015.1095401

Reference108 articles.

1. Melanoma biology and new targeted therapy

2. Increasing Incidence of Melanoma Among Young Adults: An Epidemiological Study in Olmsted County, Minnesota

3. American Cancer Society. Cancer facts & figures 2014 [Internet]. Atlanta: American Cancer Society Inc. 2013 [cited 2014 Oct 23]. Available from: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-036845.pdf.

4. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, et al. SEER cancer statistics review, 1975-2009 (Vintage 2009 Populations) [Internet]. Bethesda (MD): National Cancer Institute

5. April 2012 [cited 2014 Oct 23]. Available from: http://seer.cancer.gov/csr/1975_2009_pops09/.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the multifaceted effects of silymarin on melanoma: Focusing on the role of lipid-based nanocarriers;Journal of Drug Delivery Science and Technology;2024-09

2. A real-world retrospective, observational study of first-line pembrolizumab plus chemotherapy for metastatic non-squamous non-small cell lung cancer with PD-L1 tumor proportion score < 50% (PEMBROREAL);Frontiers in Oncology;2024-03-27

3. Effective Targeting of Melanoma Cells by Combination of Mcl-1 and Bcl-2/Bcl-xL/Bcl-w Inhibitors;International Journal of Molecular Sciences;2024-03-19

4. Nivolumab plus ipilimumab in metastatic melanoma: a critical appraisal focused on specific subpopulations;Frontiers in Oncology;2023-06-19

5. Oxidative Stress in Melanoma: Beneficial Antioxidant and Pro-Oxidant Therapeutic Strategies;Cancers;2023-06-02